Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury

Kidney International

Volumn 57, Issue 6, 2000, Pages 2445-2456

  Kanellis, John ^a   Mudge, Stuart J ^a   Fraser, Scott ^a   Katerelos, Marina ^a   Power, David A ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Apoptosis; Hypoxia; Oxygen; Renal tubules; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY TUBULE; KIDNEY TUBULE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 0034035754     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00103.x     Document Type: Article

References (49)

1. 1. FOLKMAN J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31, 1995
2. 2. FOLKMAN J, SHING Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992
3. 3. AIELLO LP, AVERY RL, ARRIGG PG, KEYT BA, JAMPEL HD, SHAH ST, PASQUALE LR, THIEME H, IWAMOTO MA, PARK JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
4. 4. ANAN K, MORISAKI T, KATANO M, IKUBO A, KITSUKI H, UCHIYAMA A, KUROKI S, TANAKA M, TORISU M: Vascular endothelial growth factor and platelet-derived growth factor arc potential angiogenic and metastatic factors in human breast cancer. Surgery 119:333-339, 1996
5. 5. DVORAK HF, SIOUSSAT TM, BROWN LF, BERSE B, NAGY JA, SOTREL A, MANSEAU EJ, VAN DE WATER L, SENGER DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174:1275-1278, 1991
6. 6. FAVA RA, OLSEN NJ, SPENCER-GREEN G, YEO KT, YEO TK, BERSE B, JACKMAN RW, SENGER DR, DVORAK HF, BROWN LF: Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341-346, 1994
7. 7. FIDLER IJ, ELLIS LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188, 1994
8. 8. YOSHIJI H, GOMEZ DE, SHIBUYA M, THORGEIRSSON UP: Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 56:2013-2016, 1996
9. 9. GERBER HP, MCMURTREY A, KOWALSKI J, YAN M, KEYT BA, DIXIT V, FERRARA N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. J Biol Chem 273:30336-30343, 1998
10. 10. GERBER HP, DIXTI V, FERRARA N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273:13313-13316, 1998
11. 11. MERRILL MJ, BACIC M, EDWARDS NA: Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12:11-15, 1995
12. 12. KEYT BA, BERLEAU LT, NGUYEN HV, CHEN H, HEINSOHN H, VANDLEN R, FERRARA N: The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795, 1996
13. 13. FERRARA N, HOUCK KA, JAKEMAN LB, WINER J, LEUNG DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218, 1991
14. 14. HOUCK KA, FERRARA N, WINER J, CACHIANES G, LI B, LEUNG DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814, 1991
15. 15. TISCHER E, MITCHELL R, HARTMAN T, SILVA M, GOSPODAROWICZ D, FIDDES JC, ABRAHAM JA: The human gene for vascular endothelial growth factor: Multiple protein forms arc encoded through alternative exon splicing. J Biol Chem 266:11947-11954, 1991
16. 16. NAMIKI A, BROGI E, KEARNEY M, KIM EA, WU T, COUFFINHAL T, VARTICOVSKI L, ISNER JM: Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270:31189-31195, 1995
17. 17. IIJIMA K, YOSHIKAWA N, CONNOLLY DT, NAKAMURA H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959-966, 1993
18. 18. IKEDA E, ACHEN MG, BREIER G, RISAU W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766, 1995
19. 19. LEVY AP, LEVY NS, WEGNER S, GOLDBERG MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340, 1995
20. 20. LEVY AP, LEVY NS, GOLDBERG MA: Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2753, 1996
21. 21. SHWEIKI D, IHN A, SOFFER D, KESHET E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
22. 22. UCHIDA K, UCHIDA S, NITTA K, YUMURA W, MARUMO F, NIHEI H: Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. Am J Physiol 266:F81-F88, 1994
23. 23. BUNN HF, POYTON RO: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76:839-885, 1996
24. 24. BANAI S, SHWEIKI D, PINSON A, CHANDRA M, LAZAROVICI G, KESHET E: Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179, 1994
25. 25. HASHIMOTO E, OGITA T, NAKAOKA T, MATSUOKA R, TAKAO A, KIRA Y: Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267:H1948-H1954, 1994
26. 26. TUDER RM, FLOOK BE, VOELKEL NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807, 1995
27. 27. KRAMER BK, BUCHER M, SANDNER P, ITTNER KP, RIEGGER GAJ, RITTHALER T, KURTZ A: Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int 51:444-447, 1997
28. 28. SANDNER P, WOLF K, BERGMAIER U, GESS B, KURTZ A: Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro. Kidney Int 51:448-453, 1997
29. 29. HUMES HD, CIESLINSKI DA, COIMBRA TM, MESSANA JM, GALVAO C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in post-ischemic acute renal failure. J Clin Invest 84:1757-1761, 1989
30. 30. SAFIRSTEIN R, PRICE PM, SAGGI SJ, HARRIS RC: Changes in gene expression after temporary renal ischemia. Kidney Int 37:1515-1521, 1990
31. 31. HOMMA T, SAKAI M, CHENG HF, YASUDA T, COFFEY RJ JR, HARRIS RC: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 96:1018-1025, 1995
32. 32. PAIZIS K, KIRKAND G, POLIHRONIS M, KATERELOS M, KANELLIS J, POWER DA: Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy. Kidney Int 53:1162-1171, 1998
33. 33. NADASDY T, LASZIK Z, BLICK KE, JOHNSON DL, SILVA FG: Tubular atrophy in the end-stage kidney: A lectin and immunohistochemical study. Hum Pathol 25:22-28, 1994
34. 34. HJELMELAND LM, CHRAMBACH A: Solubilization of functional membrane proteins. Methods Enzymol 104:305-328, 1984
35. 35. EGERTON M, BURGESS WH, CHEN D, DRUKER BJ, BREISCHER A, SAMELSON LE: Identification of ezrin as an 81-kda tyrosine-phosphorylated protein in T cells. J Immunol 149:1847-1852, 1992
36. 36. CONN G, BAYNE ML, SODERMAN DD, KWOK PW, SULLIVAN KA, PALISI TM, HOPE DA, THOMAS KA: Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632, 1990
37. 37. TSO JY, SUN X, KOA T, RFFOF KS, WU R: Isolation and characterisation of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Molecular complexity and evolution of the gene. Nucleic Acid Res 13:2485-2502, 1985
38. 38. DALLMAN MJ, PORTER CG: Semi-quantitative PCR for the analysis of gene expression, in PCR: A Practical Approach, edited by MCPHERSON MJ, QUIRKE P, TAYLOR GR, Oxford, Oxford University Press, 1991, pp 215-224
39. 39. PENNY MJ, BOYD RA, HALI BM: Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 51:1059-1068, 1997
40. 40. YU L, GENGARO PE, NIEDERBERGER M, BURKF TJ, SCHRIFR RW: Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 91:1691-1695, 1994
41. 41. HOUCK KA, LEUNG DW, ROWLAND AM, WINER J, FERRARA N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037, 1992
42. 42. PARK JE, KLLIER GA, FERRARA N: The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326, 1993
43. 43. GITAY-GOREN H, SOKER S, VLODAVSKY I, NFUFELD G: The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267:6093-6098, 1992
44. 44. PLOUET J, MORO F, BFRTAGNOLLI S, COLDEBOEUF N, MAZARGUH H, CLAMENS S, BAYARD F: Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J Biol Chem 272:13390-13396, 1997
45. 45. LI J, BROWN LF, HIBBERD MG, GROSSMAN JD, MORGAN JP, SIMONS M: VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270:H1803-H1811, 1996
46. 46. SANDNER P, WoLL K, BFRGMAIER U, GESS B, KURTZ A: Hypoxia and cobalt stimulate vascular endothelial growth factor receptor gene expression in rats. Pflügers Arch 433:803-808, 1997
47. 47. BRFZIS M, EPSTEIN FH: Cellular mechanisms of acute ischemic injury in the kidney. Annu Rev Med 44:27-37, 1993
48. 48. BRFZIS M, ROSEN S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 332:647-655, 1995
49. 49. SILVA P: Renal fuel utilization, energy requirements, and function. Kidney Int 32(Suppl 22):S9-S14, 1987